Request for Proposals - RSV Modelling Group

The Consortium has opened a new Request for Proposals (RfP).​

Through this RfP, the Consortium seeks to recruit one new modelling group to evaluate the impact of respiratory syncytial virus (RSV) vaccination across eligible countries, supported by Gavi, the Vaccine Alliance. The scope of RSV vaccine use should align with current WHO and SAGE guidance, including recommendations outlined in the Weekly Epidemiological Record (WHO, 2025).

Up to USD $73,000 in funding is available. The selected group will join the Consortium from early 2026 for one year.

Applicants must be university-based and have an existing, operational model.

For further eligibility information please read our comprehensive Guide for Applicants. If you have any questions not covered in the guide, please contact vimc@imperial.ac.uk.

Application process:

1. Access the Application Form here. 

2. Email vimc@imperial.ac.uk to register your interest and receive the Montagu link through which you can download coverage and demography for an anonymised country.

3. Submit all required documents (as specified in the Guide for Applicants) to vimc@imperial.ac.uk with the subject line ‘RfP RSV’ by the closing date.

RfP closing date: 8 December 2025.